Skip to content Skip to footer
Subscribe Now
VIEWPOINTS

Breaking New Ground in Oncology: Leonard Mazur from Citius Pharmaceuticals in Conversation with PharmaShots 

Shots:   Citius Pharmaceuticals celebrates its first-ever FDA approval with Lymphir, a novel therapy for relapsed or refractory cutaneous T-cell lymphoma     In an exclusive conversation, Leonard Mazur, Co-Founder and CEO at Citius Pharmaceuticals, shares insights on Lymphir’s launch strategy and its potential impact on the oncology landscape    Leonard also highlights Mino-Lok, Citius’ innovative…
21 hours ago

Read more

EVENTS

Post Conference Highlights: Peptides & Complex Generics Symposium 2025

Day 1 Breakdown The #PCG2025 Symposium commenced on an inspiring note, setting the stage for two days of insightful discussions, collaborations, and knowledge exchange. Opening Session Dr. Ratnesh Jain, Founder & Director, Mumbai Cluster, delivered the inaugural address, sharing his vision of bringing together pharma professionals, R&D experts, CXOs, and academicians to accelerate advancements in…
September 29, 2025

Read more

VIEWPOINTS_Jane Reed_2023
VIEWPOINTS

Jane Reed Highlights the Growing Dependence of NLP to Comply with the Regulatory Guidelines

Shots:  In an invigorating conversation with PharmaShots, Jane Reed discusses the transition from document-driven to data-driven decision-making in the pharmaceutical industry   Jane sheds light on the increasing dependence on AI and ML in regulatory affairs and how it helps pharma companies mitigate errors, discrepancies, and non-compliance   Jane highlights the benefits of NLP in ensuring regulatory…
November 16, 2023

Read more